(Bloomberg) A short-seller who sought to expose accounting fraud at skin-graft maker MiMedx Group Inc. claimed in a defamation lawsuit that the company hired a private investigator to dig up information it used to try to discredit him.
Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase 3.
MIMEDX Announces Second Quarter 2021 Operating and Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr. Timothy Wright, and Dr. Phyllis Gardner
Entirely Reconstituted Board and New Management Team Positioned Company for Long-Term Sustainable Growth; Stock Price Appreciation of 237% Since Timothy Wright Selected as CEO
Virtual Annual Meeting to Be Held on May 27, 2021
MARIETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) MIMEDX Group, Inc. (NASDAQ: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders (“Annual Meeting”), to be held virtually on May 27, 2021 at 10:00 a.m. Eastern Time at www.cesonlineservices.com/mdxg21 vm. MIMEDX shareholders of record at as of 5:00 p.m. Eastern Time on April 16, 20
Freddie, the 'one kidney wonder kid' inspires Cambridgeshire mum to walk for Kidney Research UK fenlandcitizen.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fenlandcitizen.co.uk Daily Mail and Mail on Sunday newspapers.